Rafael Gual Cosío, director general of the Cámara Nacional de la Industria Farmacéutica (CANIFARMA), the umbrella industry association for the healthcare sector in Mexico, shares his perspectives on the complex situation in the Mexican healthcare landscape today; the importance of positive and open working relationships between the public and private sectors; and the great opportunities in Mexico that can be capitalized on in the right policy environment.
Mexico has truly great opportunities, some of which we can capture in the short term – such as clinical research – and some of which we could capitalize on in the middle to long term
